SCHEMBL14923707

SCHEMBL14923707

CCC[C@H](CN1C(=O)c2ccccc2C1=O)Nc1nc(Cl)c(C#N)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGK1 P00558 1/20 0.38
▸ ALDH1A1 P00352 6/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ KHK P50053 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ ACHE P22303 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ GLA P06280 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ DRD3 P35462 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ F2 P00734 1/20 0.33
▸ F7 P08709 1/20 0.33
▸ F3 P13726 1/20 0.33
▸ BCHE P06276 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14923516 0.94 PGK1 (0.37) PGK1ALDH1A1SMN1; SMN2KHKCYP1A2
SCHEMBL3345311 0.90 ALDH1A1 (0.36) PGK1ALDH1A1SMN1; SMN2KHKCYP1A2
SCHEMBL14923606 0.89 ALDH1A1 (0.38) PGK1ALDH1A1SMN1; SMN2KHKCYP1A2
SCHEMBL14923600 0.89 ALDH1A1 (0.38) PGK1ALDH1A1SMN1; SMN2KHKCYP1A2
SCHEMBL16165769 0.87 ACHE (0.40) PGK1ALDH1A1SMN1; SMN2KHKCYP1A2
SCHEMBL15081454 0.87 ACHE (0.40) PGK1ALDH1A1SMN1; SMN2KHKCYP1A2
SCHEMBL14911298 0.87 ALDH1A1 (0.40) PGK1ALDH1A1SMN1; SMN2KHKCYP1A2
SCHEMBL14911299 0.87 ALDH1A1 (0.40) PGK1ALDH1A1SMN1; SMN2KHKCYP1A2
SCHEMBL16165713 0.86 ALDH1A1 (0.35) PGK1ALDH1A1SMN1; SMN2KHKCYP1A2
SCHEMBL16165714 0.86 ALDH1A1 (0.35) PGK1ALDH1A1SMN1; SMN2KHKCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 — — US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 — — US disclosed
US-8809371-B2 — — 2014-08-19 — — US disclosed
US-8809371-B2 — — 2014-08-19 — — US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 — — US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 — — US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK PGK1 4462/4885ALDH1A1 1638/4885SMN1; SMN2 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback